• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PAA 0.00% 21.0¢

PHARMAUST LIMITED - Announcements

PharmAust Limited is a clinical-stage biotechnology company developing therapeutics for... PharmAust Limited is a clinical-stage biotechnology company developing therapeutics for human and animal health applications. The Company’s segments include Corporate and Research. The Company is focused on repurposing monepantel (MPL) for human neurodegenerative diseases. The Company's lead candidate, Monepantel (MPL), is a potent and safe inhibitor of the mTOR pathway, that plays a central role in cell growth and proliferation of cancer cells and in degenerating neurons. The Company is also developing MPL as a treatment for motor neuron disease (MND/ALS), a rare, incurable disease. It is focused on starting Phase II/III clinical study of MPL. It has also completed a Phase II oncology clinical study of MPL in humans and pilot studies in canine cancer. It is also preparing a pivotal monepantel field trial in dogs with B-Cell Lymphoma to enable product registration in the United States.More

Announcements


PAA Appendix 4D & Financial Report - Dec 2016PRICE SENSITIVE28/02/17 download Created with Sketch. 488.8KB
PAA Appendix 4C - Quarterly Report & Company UpdatePRICE SENSITIVE31/01/17 download Created with Sketch. 499.17KB
PAA PharmAust Receives $406K R&D Rebate from ATOPRICE SENSITIVE30/01/17 download Created with Sketch. 253.13KB
PAA Appendix 3B & s708 Notice03/01/17 download Created with Sketch. 795.25KB
PAA PharmAust raises a further $1.56m30/12/16 download Created with Sketch. 234.8KB
PAA Change of Director's Interest Notice x 413/12/16 download Created with Sketch. 521KB
PAA Completion of Rights Issue & Notice of Shortfall08/12/16 download Created with Sketch. 256.06KB
PAA No Extension of Closing Date in Rights Issue06/12/16 download Created with Sketch. 237.11KB
PAA Rights Issue - Extension of Closing Date05/12/16 download Created with Sketch. 329.53KB
PAA Phase II Strategy UpdatePRICE SENSITIVE21/11/16 download Created with Sketch. 374.42KB
PAA Results of Annual General Meeting11/11/16 download Created with Sketch. 91.07KB
PAA PharmAust AGM Presentation11/11/16 download Created with Sketch. 1.57MB
PAA Appendix 3B08/11/16 download Created with Sketch. 753.39KB
PAA Letter to Optionholders08/11/16 download Created with Sketch. 141.62KB
PAA ProspectusPRICE SENSITIVE08/11/16 download Created with Sketch. 582.35KB
PAA Appendix 4C - Quarterly Report & Company Update-PAA.AX PRICE SENSITIVE31/10/16 download Created with Sketch. 506.29KB
PAA Second canine receives treatment in trial-PAA.AX 14/10/16 download Created with Sketch. 247.2KB
PAA Notice of Annual General Meeting/Proxy Form-PAA.AX 11/10/16 download Created with Sketch. 394.38KB
PAA Phase II Canine Trial begins at University of Cambridge-PAA.AX PRICE SENSITIVE19/09/16 download Created with Sketch. 245.74KB
PAA Epichem achieves ISO 9001 2015 certification-PAA.AX PRICE SENSITIVE16/09/16 download Created with Sketch. 330.74KB
PAA MPL capsules shipped to centres in NSW & Qld for Phase II-PAA.AX PRICE SENSITIVE13/09/16 download Created with Sketch. 239.11KB
PAA Appendix 4G & Corporate Governance Statement-PAA.AX 31/08/16 download Created with Sketch. 614.98KB
PAA Appendix 4E & Full Year Statutory Accounts 2016-PAA.AX PRICE SENSITIVE31/08/16 download Created with Sketch. 921.98KB
PAA PharmAust Investor Presentation - August 2016-PAA.AX 29/08/16 download Created with Sketch. 942.58KB
PAA Further Canine Trials to be Initiated in Australia-PAA.AX PRICE SENSITIVE10/08/16 download Created with Sketch. 240.85KB
PAA IP exchange with UNSW consolidates MPL patent position-PAA.AX PRICE SENSITIVE03/08/16 download Created with Sketch. 244.49KB
PAA Appendix 4C Quarterly & Brief Company Update - June 2016-PAA.AX PRICE SENSITIVE29/07/16 download Created with Sketch. 521.15KB
PAA Investor Call-PAA.AX 19/07/16 download Created with Sketch. 303.89KB
PAA Reformulated MPL capsules completed, Phase II to commence-PAA.AX PRICE SENSITIVE11/07/16 download Created with Sketch. 249.43KB
PAA University of Cambridge to begin Phase II Trial-PAA.AX PRICE SENSITIVE27/06/16 download Created with Sketch. 241.11KB
PAA Epichem Successful in AusTrade Grant-PAA.AX PRICE SENSITIVE16/06/16 download Created with Sketch. 242.12KB
PAA Mandate signed to raise capital in USA & list on NASDAQ-PAA.AX 02/06/16 download Created with Sketch. 245.49KB
PAA Appendix 4C Quarterly Report & Brief Company Update-PAA.AX PRICE SENSITIVE29/04/16 download Created with Sketch. 521.82KB
PAA RedChip issues research on PharmAust11/03/16 download Created with Sketch. 423.95KB
PAA Strategy for Phase II Clinical Trial of MonepantelPRICE SENSITIVE08/03/16 download Created with Sketch. 229.79KB
PAA Appendix 4D & Half Yearly Report and AccountsPRICE SENSITIVE29/02/16 download Created with Sketch. 610.99KB
PAA PharmAust Featured on The RedChip Money Report on Bloomberg12/02/16 download Created with Sketch. 233.81KB
PAA PharmAust to Present at RedChip Global Online Microcap Conf08/02/16 download Created with Sketch. 315.64KB
PAA Notice of Allowance received from USA Patent OffIcePRICE SENSITIVE05/02/16 download Created with Sketch. 302.87KB
PAA PharmAust Receives $546K R&D Rebate from ATOPRICE SENSITIVE01/02/16 download Created with Sketch. 249.02KB
PAA Appendix 4C - Quarterly Report & Company UpdatePRICE SENSITIVE29/01/16 download Created with Sketch. 462.56KB
PAA USA Roadshow Presentation - January 201618/01/16 download Created with Sketch. 686.5KB
PAA Juniper Pharma Services to reformulate MPL for Phase IIPRICE SENSITIVE11/01/16 download Created with Sketch. 408.28KB
PAA PharmAust Featured on RedChip Money Report on Bloomberg04/01/16 download Created with Sketch. 237.7KB
PAA Epichem Awarded Two Year Contract Extension from DNDiPRICE SENSITIVE21/12/15 download Created with Sketch. 240.64KB
PAA Change of Director's Interest Notice08/12/15 download Created with Sketch. 414.26KB
PAA Appendix 3B & 708 Notice04/12/15 download Created with Sketch. 794.16KB
PAA Change of Director's Interest Notice03/12/15 download Created with Sketch. 413.9KB
PAA Change of Director's Interest Notice02/12/15 download Created with Sketch. 412.04KB
PAA GenScript Further Pre-Clinical Validation for Phase II TrialPRICE SENSITIVE26/11/15 download Created with Sketch. 231.33KB
PAA RedChip appointed to begin Global Investor Relations Program24/11/15 download Created with Sketch. 245.4KB
PAA Change of Director's Interest Notice06/11/15 download Created with Sketch. 413.93KB
PAA Change of Director's Interest Notice05/11/15 download Created with Sketch. 413.58KB
PAA Appendix 3B05/11/15 download Created with Sketch. 751.48KB
PAA Quarterly Report & Company UpdatePRICE SENSITIVE30/10/15 download Created with Sketch. 658.84KB
PAA Consolidation of Capital28/10/15 download Created with Sketch. 124.39KB
PAA Final Director's Interest Notice28/10/15 download Created with Sketch. 311.9KB
PAA Results of Annual General Meeting27/10/15 download Created with Sketch. 93.31KB
PAA PharmAust AGM Presentation 201527/10/15 download Created with Sketch. 2.86MB
PAA Change of Director's Interest Notice22/10/15 download Created with Sketch. 410.18KB
PAA Clinical Trial Report Following Phase I TrialPRICE SENSITIVE21/10/15 download Created with Sketch. 271.77KB
PAA Change of Registered Office & Principal Place of Business19/10/15 download Created with Sketch. 240.76KB
PAA Epichem's New Laboratory Completed29/09/15 download Created with Sketch. 309.45KB
PAA Consolidation/Split - PAAPRICE SENSITIVE22/09/15 download Created with Sketch. 32.84KB
PAA PharmAust Annual Report 201522/09/15 download Created with Sketch. 1.27MB
PAA Notice of Annual General Meeting/Proxy FormPRICE SENSITIVE22/09/15 download Created with Sketch. 432.3KB
PAA Appendix 3B & 708 Notice04/09/15 download Created with Sketch. 792.72KB
PAA Appendix 4E & Full Year Statutory AccountsPRICE SENSITIVE28/08/15 download Created with Sketch. 1.1MB
PAA Appendix 4G & Corporate Governance Statement28/08/15 download Created with Sketch. 614.44KB
PAA Professor Morris plans to retire from PharmAust board24/08/15 download Created with Sketch. 228.28KB
PAA Change of Director's Interest Notice12/08/15 download Created with Sketch. 411.19KB
PAA Clarification on Expiry of Listed Options03/08/15 download Created with Sketch. 73.47KB
PAA Letter to Optionholders03/08/15 download Created with Sketch. 295.88KB
PAA Appendix 4C - Quarterly Report & Company UpdatePRICE SENSITIVE28/07/15 download Created with Sketch. 647.49KB
PAA Phase I Trial at RAH Meets Safety & Cancer Marker End PointsPRICE SENSITIVE23/07/15 download Created with Sketch. 298.28KB
PAA Trading HaltPRICE SENSITIVE22/07/15 download Created with Sketch. 243.78KB
PAA First Two Canines Complete Combination Therapy With PPL-1PRICE SENSITIVE16/07/15 download Created with Sketch. 236.5KB
PAA PharmAust Receives ATO Research & Development RebatePRICE SENSITIVE24/06/15 download Created with Sketch. 246.53KB
PAA PharmAust Initiates Combination Therapy Evaluations in Dogs17/06/15 download Created with Sketch. 237.55KB
PAA Change of registry address12/06/15 download Created with Sketch. 20.69KB
PAA Change of Share Registry Address12/06/15 download Created with Sketch. 20.69KB
PAA Appendix 3B & s708 Notice02/06/15 download Created with Sketch. 873.76KB
PAA Results of Meeting26/05/15 download Created with Sketch. 86.41KB
PAA EGM Shareholder Presentation26/05/15 download Created with Sketch. 433.25KB
PAA Second Dog Shows Suppression of Cancer Marker at Days 3 & 7PRICE SENSITIVE19/05/15 download Created with Sketch. 238.94KB
PAA Reduction of further Cancer Marker confirmed in Human TrialPRICE SENSITIVE11/05/15 download Created with Sketch. 303.76KB
PAA First Dog Shows Suppression of Cancer MarkerPRICE SENSITIVE01/05/15 download Created with Sketch. 237.76KB
PAA Appendix 4C Quarterly Report & Company UpdatePRICE SENSITIVE22/04/15 download Created with Sketch. 602.63KB
PAA Notice of General Meeting/Proxy Form21/04/15 download Created with Sketch. 331.07KB
PAA Approval of Dose Escalation of PPL-1 in Human TrialPRICE SENSITIVE15/04/15 download Created with Sketch. 333.2KB
PAA Modification of Clinical Trial in DogsPRICE SENSITIVE13/04/15 download Created with Sketch. 240.92KB
PAA Lyell McEwin Hospital approved to join PharmAust trialPRICE SENSITIVE08/04/15 download Created with Sketch. 322.01KB
PAA PharmAust Broker Roadshow Presentation - April 201501/04/15 download Created with Sketch. 5.56MB
PAA Joint Patent with Japanese Corporation now publishedPRICE SENSITIVE31/03/15 download Created with Sketch. 230.1KB
PAA Final Patient in Cohort Demonstrates Tumour Marker ReductionPRICE SENSITIVE24/03/15 download Created with Sketch. 260.07KB
PAA Appendix 3B and s708 Notice20/03/15 download Created with Sketch. 878.76KB
PAA PharmAust Shareholder Presentation - March 201519/03/15 download Created with Sketch. 5.62MB
PAA Completion of Lowest Dose Cohort in Human Cancer TrialPRICE SENSITIVE17/03/15 download Created with Sketch. 235.12KB
PAA PharmAust completes $3.14m Share Placement oversubscribedPRICE SENSITIVE16/03/15 download Created with Sketch. 235.96KB
PAA Trading HaltPRICE SENSITIVE12/03/15 download Created with Sketch. 207.65KB
PAA Appendix 4D & Financial Report - Dec 2016
28/02/17PRICE SENSITIVE download Created with Sketch. 488.8KB
PAA Appendix 4C - Quarterly Report & Company Update
31/01/17PRICE SENSITIVE download Created with Sketch. 499.17KB
PAA PharmAust Receives $406K R&D Rebate from ATO
30/01/17PRICE SENSITIVE download Created with Sketch. 253.13KB
PAA Appendix 3B & s708 Notice
03/01/17 download Created with Sketch. 795.25KB
PAA PharmAust raises a further $1.56m
30/12/16 download Created with Sketch. 234.8KB
PAA Change of Director's Interest Notice x 4
13/12/16 download Created with Sketch. 521KB
PAA Completion of Rights Issue & Notice of Shortfall
08/12/16 download Created with Sketch. 256.06KB
PAA No Extension of Closing Date in Rights Issue
06/12/16 download Created with Sketch. 237.11KB
PAA Rights Issue - Extension of Closing Date
05/12/16 download Created with Sketch. 329.53KB
PAA Phase II Strategy Update
21/11/16PRICE SENSITIVE download Created with Sketch. 374.42KB
PAA Results of Annual General Meeting
11/11/16 download Created with Sketch. 91.07KB
PAA PharmAust AGM Presentation
11/11/16 download Created with Sketch. 1.57MB
PAA Appendix 3B
08/11/16 download Created with Sketch. 753.39KB
PAA Letter to Optionholders
08/11/16 download Created with Sketch. 141.62KB
PAA Prospectus
08/11/16PRICE SENSITIVE download Created with Sketch. 582.35KB
PAA Appendix 4C - Quarterly Report & Company Update-PAA.AX
31/10/16PRICE SENSITIVE download Created with Sketch. 506.29KB
PAA Second canine receives treatment in trial-PAA.AX
14/10/16 download Created with Sketch. 247.2KB
PAA Notice of Annual General Meeting/Proxy Form-PAA.AX
11/10/16 download Created with Sketch. 394.38KB
PAA Phase II Canine Trial begins at University of Cambridge-PAA.AX
19/09/16PRICE SENSITIVE download Created with Sketch. 245.74KB
PAA Epichem achieves ISO 9001 2015 certification-PAA.AX
16/09/16PRICE SENSITIVE download Created with Sketch. 330.74KB
PAA MPL capsules shipped to centres in NSW & Qld for Phase II-PAA.AX
13/09/16PRICE SENSITIVE download Created with Sketch. 239.11KB
PAA Appendix 4G & Corporate Governance Statement-PAA.AX
31/08/16 download Created with Sketch. 614.98KB
PAA Appendix 4E & Full Year Statutory Accounts 2016-PAA.AX
31/08/16PRICE SENSITIVE download Created with Sketch. 921.98KB
PAA PharmAust Investor Presentation - August 2016-PAA.AX
29/08/16 download Created with Sketch. 942.58KB
PAA Further Canine Trials to be Initiated in Australia-PAA.AX
10/08/16PRICE SENSITIVE download Created with Sketch. 240.85KB
PAA IP exchange with UNSW consolidates MPL patent position-PAA.AX
03/08/16PRICE SENSITIVE download Created with Sketch. 244.49KB
PAA Appendix 4C Quarterly & Brief Company Update - June 2016-PAA.AX
29/07/16PRICE SENSITIVE download Created with Sketch. 521.15KB
PAA Investor Call-PAA.AX
19/07/16 download Created with Sketch. 303.89KB
PAA Reformulated MPL capsules completed, Phase II to commence-PAA.AX
11/07/16PRICE SENSITIVE download Created with Sketch. 249.43KB
PAA University of Cambridge to begin Phase II Trial-PAA.AX
27/06/16PRICE SENSITIVE download Created with Sketch. 241.11KB
PAA Epichem Successful in AusTrade Grant-PAA.AX
16/06/16PRICE SENSITIVE download Created with Sketch. 242.12KB
PAA Mandate signed to raise capital in USA & list on NASDAQ-PAA.AX
02/06/16 download Created with Sketch. 245.49KB
PAA Appendix 4C Quarterly Report & Brief Company Update-PAA.AX
29/04/16PRICE SENSITIVE download Created with Sketch. 521.82KB
PAA RedChip issues research on PharmAust
11/03/16 download Created with Sketch. 423.95KB
PAA Strategy for Phase II Clinical Trial of Monepantel
08/03/16PRICE SENSITIVE download Created with Sketch. 229.79KB
PAA Appendix 4D & Half Yearly Report and Accounts
29/02/16PRICE SENSITIVE download Created with Sketch. 610.99KB
PAA PharmAust Featured on The RedChip Money Report on Bloomberg
12/02/16 download Created with Sketch. 233.81KB
PAA PharmAust to Present at RedChip Global Online Microcap Conf
08/02/16 download Created with Sketch. 315.64KB
PAA Notice of Allowance received from USA Patent OffIce
05/02/16PRICE SENSITIVE download Created with Sketch. 302.87KB
PAA PharmAust Receives $546K R&D Rebate from ATO
01/02/16PRICE SENSITIVE download Created with Sketch. 249.02KB
PAA Appendix 4C - Quarterly Report & Company Update
29/01/16PRICE SENSITIVE download Created with Sketch. 462.56KB
PAA USA Roadshow Presentation - January 2016
18/01/16 download Created with Sketch. 686.5KB
PAA Juniper Pharma Services to reformulate MPL for Phase II
11/01/16PRICE SENSITIVE download Created with Sketch. 408.28KB
PAA PharmAust Featured on RedChip Money Report on Bloomberg
04/01/16 download Created with Sketch. 237.7KB
PAA Epichem Awarded Two Year Contract Extension from DNDi
21/12/15PRICE SENSITIVE download Created with Sketch. 240.64KB
PAA Change of Director's Interest Notice
08/12/15 download Created with Sketch. 414.26KB
PAA Appendix 3B & 708 Notice
04/12/15 download Created with Sketch. 794.16KB
PAA Change of Director's Interest Notice
03/12/15 download Created with Sketch. 413.9KB
PAA Change of Director's Interest Notice
02/12/15 download Created with Sketch. 412.04KB
PAA GenScript Further Pre-Clinical Validation for Phase II Trial
26/11/15PRICE SENSITIVE download Created with Sketch. 231.33KB
PAA RedChip appointed to begin Global Investor Relations Program
24/11/15 download Created with Sketch. 245.4KB
PAA Change of Director's Interest Notice
06/11/15 download Created with Sketch. 413.93KB
PAA Change of Director's Interest Notice
05/11/15 download Created with Sketch. 413.58KB
PAA Appendix 3B
05/11/15 download Created with Sketch. 751.48KB
PAA Quarterly Report & Company Update
30/10/15PRICE SENSITIVE download Created with Sketch. 658.84KB
PAA Consolidation of Capital
28/10/15 download Created with Sketch. 124.39KB
PAA Final Director's Interest Notice
28/10/15 download Created with Sketch. 311.9KB
PAA Results of Annual General Meeting
27/10/15 download Created with Sketch. 93.31KB
PAA PharmAust AGM Presentation 2015
27/10/15 download Created with Sketch. 2.86MB
PAA Change of Director's Interest Notice
22/10/15 download Created with Sketch. 410.18KB
PAA Clinical Trial Report Following Phase I Trial
21/10/15PRICE SENSITIVE download Created with Sketch. 271.77KB
PAA Change of Registered Office & Principal Place of Business
19/10/15 download Created with Sketch. 240.76KB
PAA Epichem's New Laboratory Completed
29/09/15 download Created with Sketch. 309.45KB
PAA Consolidation/Split - PAA
22/09/15PRICE SENSITIVE download Created with Sketch. 32.84KB
PAA PharmAust Annual Report 2015
22/09/15 download Created with Sketch. 1.27MB
PAA Notice of Annual General Meeting/Proxy Form
22/09/15PRICE SENSITIVE download Created with Sketch. 432.3KB
PAA Appendix 3B & 708 Notice
04/09/15 download Created with Sketch. 792.72KB
PAA Appendix 4E & Full Year Statutory Accounts
28/08/15PRICE SENSITIVE download Created with Sketch. 1.1MB
PAA Appendix 4G & Corporate Governance Statement
28/08/15 download Created with Sketch. 614.44KB
PAA Professor Morris plans to retire from PharmAust board
24/08/15 download Created with Sketch. 228.28KB
PAA Change of Director's Interest Notice
12/08/15 download Created with Sketch. 411.19KB
PAA Clarification on Expiry of Listed Options
03/08/15 download Created with Sketch. 73.47KB
PAA Letter to Optionholders
03/08/15 download Created with Sketch. 295.88KB
PAA Appendix 4C - Quarterly Report & Company Update
28/07/15PRICE SENSITIVE download Created with Sketch. 647.49KB
PAA Phase I Trial at RAH Meets Safety & Cancer Marker End Points
23/07/15PRICE SENSITIVE download Created with Sketch. 298.28KB
PAA Trading Halt
22/07/15PRICE SENSITIVE download Created with Sketch. 243.78KB
PAA First Two Canines Complete Combination Therapy With PPL-1
16/07/15PRICE SENSITIVE download Created with Sketch. 236.5KB
PAA PharmAust Receives ATO Research & Development Rebate
24/06/15PRICE SENSITIVE download Created with Sketch. 246.53KB
PAA PharmAust Initiates Combination Therapy Evaluations in Dogs
17/06/15 download Created with Sketch. 237.55KB
PAA Change of registry address
12/06/15 download Created with Sketch. 20.69KB
PAA Change of Share Registry Address
12/06/15 download Created with Sketch. 20.69KB
PAA Appendix 3B & s708 Notice
02/06/15 download Created with Sketch. 873.76KB
PAA Results of Meeting
26/05/15 download Created with Sketch. 86.41KB
PAA EGM Shareholder Presentation
26/05/15 download Created with Sketch. 433.25KB
PAA Second Dog Shows Suppression of Cancer Marker at Days 3 & 7
19/05/15PRICE SENSITIVE download Created with Sketch. 238.94KB
PAA Reduction of further Cancer Marker confirmed in Human Trial
11/05/15PRICE SENSITIVE download Created with Sketch. 303.76KB
PAA First Dog Shows Suppression of Cancer Marker
01/05/15PRICE SENSITIVE download Created with Sketch. 237.76KB
PAA Appendix 4C Quarterly Report & Company Update
22/04/15PRICE SENSITIVE download Created with Sketch. 602.63KB
PAA Notice of General Meeting/Proxy Form
21/04/15 download Created with Sketch. 331.07KB
PAA Approval of Dose Escalation of PPL-1 in Human Trial
15/04/15PRICE SENSITIVE download Created with Sketch. 333.2KB
PAA Modification of Clinical Trial in Dogs
13/04/15PRICE SENSITIVE download Created with Sketch. 240.92KB
PAA Lyell McEwin Hospital approved to join PharmAust trial
08/04/15PRICE SENSITIVE download Created with Sketch. 322.01KB
PAA PharmAust Broker Roadshow Presentation - April 2015
01/04/15 download Created with Sketch. 5.56MB
PAA Joint Patent with Japanese Corporation now published
31/03/15PRICE SENSITIVE download Created with Sketch. 230.1KB
PAA Final Patient in Cohort Demonstrates Tumour Marker Reduction
24/03/15PRICE SENSITIVE download Created with Sketch. 260.07KB
PAA Appendix 3B and s708 Notice
20/03/15 download Created with Sketch. 878.76KB
PAA PharmAust Shareholder Presentation - March 2015
19/03/15 download Created with Sketch. 5.62MB
PAA Completion of Lowest Dose Cohort in Human Cancer Trial
17/03/15PRICE SENSITIVE download Created with Sketch. 235.12KB
PAA PharmAust completes $3.14m Share Placement oversubscribed
16/03/15PRICE SENSITIVE download Created with Sketch. 235.96KB
PAA Trading Halt
12/03/15PRICE SENSITIVE download Created with Sketch. 207.65KB
(20min delay)
Last
21.0¢
Change
0.000(0.00%)
Mkt cap ! $93.45M
Open High Low Value Volume
21.0¢ 21.5¢ 20.5¢ $106.7K 516.1K

Buyers (Bids)

No. Vol. Price($)
2 24033 20.5¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 55077 2
View Market Depth
Last trade - 15.22pm 22/07/2024 (20 minute delay) ?
Last
21.0¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
21.0¢ 21.0¢ 20.5¢ 342599
Last updated 15.22pm 22/07/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.